FDA Drug Application (202239) for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE by AUROBINDO PHARMA LTD

Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Application Number202239
Product Number001
FormCAPSULE;ORAL
DosageEQ 2.5MG BASE;10MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameAMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Active IngredientAMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient AMLODIPINE BESYLATE21
List of drugs with Active Ingredient BENAZEPRIL HYDROCHLORIDE8


Back to FDA Applications sponsored by AUROBINDO PHARMA LTD